August 31, 2017 — Hologic Inc. announced U.S. commercial availability of the Breverabreast biopsy systemwith CorLumina imaging technology, a real-timebreast biopsyand verification system. The system enhances workflow, improves the patient experience and streamlines the entirebiopsyprocess from start to finish. It is designed to increase biopsy accuracy with real-time imaging that delivers valuable information at the point of care, enabling clinicians to make informed decisions with confidence.
The Brevera system is the world's first and only breast biopsy solution to combine tissue acquisition,real-time imaging根据Hologic，样品验证和先进的活检后处理在一个集成的系统中。该系统专为2-D和3-D乳腺活检而设计，允许医生进行快速高效的手术，节省成本，改善患者体验。1
Until now, radiologists performing stereotactic breast biopsy procedures to diagnosebreast cancerwere often required to leave the patient under compression while they moved to another room to image and verify tissue samples. This leads to lengthy procedure times and anxious, uncomfortable patients, and can interrupt facility screening schedules. With the Brevera system, radiologists are able to obtain and image tissue samples in the procedure room in just a few seconds, potentially saving up to 10 minutes per patient and cutting the procedure time by up to 25 percent.2
In addition to saving facility resources and physician time during a breast biopsy procedure, the Brevera system's proprietary CorLumina imaging technology helps enhance workflow across multiple departments within a health system. The system automates the tissue sample collection and separation process, which allows patient tissue to be sent to pathology with little or no manual handling and protects the integrity of samples. The system also features picture archiving and communication system (PACS) integration for advanced image sharing and transfer of patient records.
The Brevera system is designed for use with Hologic's Affirm prone biopsy system, Affirm breast biopsy guidance system and MultiCare Platinum system, as well as most upright and prone systems on the market.
For more information:www.hologic.com
References
1. 3-D biopsy only when used with the Affirm breast biopsy system.
2. 2015 Kadence International survey of 200 healthcare professionals.
August 16, 2022
